PROTO LABS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 31.37 USD | -0.16% |
|
-1.85% | -19.48% |
| Feb. 12 | Craig-Hallum Adjusts Proto Labs Price Target to $38 From $30, Maintains Hold Rating | MT |
| Feb. 09 | Transcript : Proto Labs, Inc., Q4 2023 Earnings Call, Feb 09, 2024 |
Valuation
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Capitalization 1 | 2,717 | 4,104 | 1,417 | 692.3 | 1,005 | 801.8 | - |
| Enterprise Value (EV) 1 | 2,557 | 3,942 | 1,341 | 629.7 | 1,005 | 801.8 | 801.8 |
| P/E ratio | 43.2 x | 81.2 x | 42.4 x | -6.77 x | 59 x | 32.5 x | 28 x |
| Yield | - | - | - | - | - | - | - |
| Capitalization / Revenue | 5.92 x | 9.45 x | 2.9 x | 1.42 x | 1.99 x | 1.55 x | 1.48 x |
| EV / Revenue | 5.92 x | 9.45 x | 2.9 x | 1.42 x | 1.99 x | 1.55 x | 1.48 x |
| EV / EBITDA | 22.4 x | 38 x | 15.8 x | 8.31 x | 12.1 x | 9.74 x | 9.22 x |
| EV / FCF | 50,489,030 x | 68,446,666 x | 67,357,410 x | 17,138,964 x | - | - | - |
| FCF Yield | 0% | 0% | 0% | 0% | - | - | - |
| Price to Book | 4.64 x | 6.37 x | 1.7 x | 0.99 x | - | - | - |
| Nbr of stocks (in thousands) | 26,759 | 26,754 | 27,590 | 27,117 | 25,786 | 25,560 | - |
| Reference price 2 | 101.6 | 153.4 | 51.35 | 25.53 | 38.96 | 31.37 | 31.37 |
| Announcement Date | 2/6/20 | 2/12/21 | 2/11/22 | 2/10/23 | 2/9/24 | - | - |
1USD in Million2USD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Net sales 1 | 458.7 | 434.4 | 488.1 | 488.4 | 503.9 | 516.3 | 541.3 |
| EBITDA 1 | 121.4 | 107.9 | 89.52 | 83.31 | 83.23 | 82.31 | 86.94 |
| EBIT 1 | 79.86 | 59.84 | 55.02 | 50.59 | 50.3 | 50.49 | 56.04 |
| Operating Margin | 17.41% | 13.77% | 11.27% | 10.36% | 9.98% | 9.78% | 10.35% |
| Earnings before Tax (EBT) 1 | 81.19 | 62.94 | 40.18 | -97.88 | 27.95 | 29.35 | 36.14 |
| Net income 1 | 63.66 | 50.87 | 33.37 | -103.5 | 17.22 | 22.46 | 27.83 |
| Net margin | 13.88% | 11.71% | 6.84% | -21.18% | 3.42% | 4.35% | 5.14% |
| EPS 2 | 2.350 | 1.890 | 1.210 | -3.770 | 0.6600 | 0.9667 | 1.120 |
| Free Cash Flow | 53.82 | 59.96 | 21.03 | 40.39 | - | - | - |
| FCF margin | 11.73% | 13.8% | 4.31% | 8.27% | - | - | - |
| FCF Conversion (EBITDA) | 44.33% | 55.55% | 23.5% | 48.49% | - | - | - |
| FCF Conversion (Net income) | 84.55% | 117.87% | 63.03% | - | - | - | - |
| Dividend per Share | - | - | - | - | - | - | - |
| Announcement Date | 2/6/20 | 2/12/21 | 2/11/22 | 2/10/23 | 2/9/24 | - | - |
1USD in Million2USD
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: December | 2021 Q3 | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 125.3 | 123.6 | 124.2 | 126.9 | 121.7 | 115.6 | 125.9 | 122.3 | 130.7 | 125 | 124.7 | 128.3 | 132.4 | 131 | 130.1 |
| EBITDA 1 | 21.48 | 22.23 | 22.26 | 24.59 | 21.96 | 14.49 | 17.77 | 19.23 | 23.94 | 22.3 | 17.61 | 20.64 | 22.11 | 21.94 | 20.5 |
| EBIT 1 | 12.74 | 13.45 | 13.83 | 15.95 | 13.67 | 7.134 | 9.036 | 14.96 | 16.31 | 14.06 | 9.542 | 12.27 | 14.53 | 14.15 | 12.2 |
| Operating Margin | 10.17% | 10.89% | 11.14% | 12.57% | 11.23% | 6.17% | 7.18% | 12.23% | 12.48% | 11.24% | 7.65% | 9.56% | 10.97% | 10.81% | 9.38% |
| Earnings before Tax (EBT) 1 | 7.063 | 12.93 | 7.59 | 5.202 | 6.034 | -116.7 | 5.039 | 2.24 | 10.74 | 9.938 | 4.746 | 7.394 | 8.645 | 8.566 | 6.948 |
| Net income 1 | 4.835 | 11.91 | 5.095 | 2.557 | 3.951 | -115.1 | 2.659 | -0.383 | 7.954 | 6.99 | 3.612 | 5.658 | 6.619 | 6.573 | 5.28 |
| Net margin | 3.86% | 9.64% | 4.1% | 2.01% | 3.25% | -99.53% | 2.11% | -0.31% | 6.09% | 5.59% | 2.9% | 4.41% | 5% | 5.02% | 4.06% |
| EPS 2 | 0.1700 | 0.4300 | 0.1900 | 0.0900 | 0.1400 | -4.240 | 0.1000 | -0.0100 | 0.3100 | 0.2700 | 0.1500 | 0.2300 | 0.3000 | 0.2900 | 0.2000 |
| Dividend per Share | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Announcement Date | 10/28/21 | 2/11/22 | 5/6/22 | 8/5/22 | 11/4/22 | 2/10/23 | 5/5/23 | 8/4/23 | 11/3/23 | 2/9/24 | - | - | - | - | - |
1USD in Million2USD
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Net Debt | - | - | - | - | - | - | - |
| Net Cash position | 161 | 162 | 75.6 | 62.6 | - | - | - |
| Leverage (Debt/EBITDA) | - | - | - | - | - | - | - |
| Free Cash Flow | 53.8 | 60 | 21 | 40.4 | - | - | - |
| ROE (net income / shareholders' equity) | 11.3% | - | - | - | - | - | - |
| ROA (Net income/ Total Assets) | - | - | - | - | - | - | - |
| Assets 1 | - | - | - | - | - | - | - |
| Book Value Per Share | 21.90 | 24.10 | 30.20 | 25.70 | - | - | - |
| Cash Flow per Share 2 | 4.290 | 3.980 | 2.000 | 2.290 | 2.790 | 2.810 | - |
| Capex | 62.2 | 47 | 34.2 | 21.7 | - | - | - |
| Capex / Sales | 13.57% | 10.82% | 7.01% | 4.44% | - | - | - |
| Announcement Date | 2/6/20 | 2/12/21 | 2/11/22 | 2/10/23 | 2/9/24 | - | - |
1USD in Million2USD
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
C
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
4
Last Close Price
31.37
USD
Average target price
41.5
USD
Spread / Average Target
+32.29%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -19.48% | 802M | |
| +11.73% | 82.35B | |
| +20.17% | 71.09B | |
| +20.89% | 37.72B | |
| +15.77% | 32.01B | |
| +9.19% | 27.2B | |
| +3.18% | 26.74B | |
| +4.22% | 26B | |
| +16.93% | 25.5B | |
| +17.14% | 24.76B |
- Stock Market
- Equities
- PRLB Stock
- Financials Proto Labs, Inc.
